Report - Mid-Range Growth Strategy from FY2013 - Takeda · 2020. 8. 11. · • Launch new products (TAK-491, alogliptin, etc.) • Increase competitiveness in rural area s with strong economic

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form